Latest Breaking News On - Tolerance inc view - Page 1 : comparemela.com

iTolerance, Inc to Participate in the Virtual Investor Summer Spotlight Series

iTolerance, Inc to Participate in the Virtual Investor Summer Spotlight Series
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAnthony japourSusan robertsSumitra ghateJenene thomasDennis hesterTolerance leadership team onTolerance incDevelopment global regulatory affairsTolerance inc viewTolerance leadership teamChief executive officerGlobal regulatory affairsVirtual investor summer spotlight seriesPrivate securities litigation reform actInc view

iTolerance, Inc and Kadimastem Enter into Collaboration Agreement for Development of a Potential Cure for Type 1 Diabetes and Receive US $1 0 Million Grant from the BIRD Foundation

MIAMI, FL / ACCESSWIRE / May 18, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company developing technologies to enable tissue, organoid or cell therapy

Tel avivUnited statesAnthony japourJenene thomasAsaf shiloniGewinn nurSusan robertsTolerance incIsrael innovation authorityTolerance inc viewTel aviv stock exchangeWeizmann institute of scienceBinational israel uChief executive officerHuman embryonic stem cellsProfessor michel revel

iTolerance, Inc Announces Issuance of U S Patent Covering Proprietary Regenerative SA-FasL Microgel Technology, iTOL-100

Company leveraging iTOL-100 to advance a pipeline of programs that have the potential to cure diseases, such as Type 1 Diabetes, without the need for life-long immunosuppressionMIAMI, FL / ACCESSWIRE /

United statesJenene thomasSusan robertsAnthony japourTrademark officeTolerance inc viewTolerance incHealth canadaUnited states patentL engineered biomaterialsChief executive officerPrivate securities litigation reform actInc view

iTolerance, Inc CEO to Present at the Bio LaunchPad Seminar at Georgia Tech s Institute for Bioengineering and Bioscience

Livestream presentation to be held on Thursday, March 30, 2023 at 11:00 AM ETMIAMI, FL / ACCESSWIRE / March 29, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine

United statesJenene thomasSusan robertsAnthony japourTolerance incUniversity of louisvilleTolerance inc viewChief executive officerBio launchpad seminarGeorgia techPrivate securities litigation reform actInc viewDiese gold aktieSichern sie

iTolerance, Inc Completes Pre-IND Meeting with U S FDA for Development Program as a Potential Cure for Type 1 Diabetes Without the Need for Life-long Immunosuppression

MIAMI, FL / ACCESSWIRE / March 1, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company developing technologies to enable tissue, organoid or cell therapy

United statesDennis riedlAnthony japourJenene thomasSusan robertsTolerance inc viewDrug administrationTolerance incPre investigational new drug applicationChief executive officerPrivate securities litigation reform actInc view